IHL 0.00% 4.1¢ incannex healthcare limited

General discussion, page-3717

  1. 1,958 Posts.
    lightbulb Created with Sketch. 4359
    Further data show IL-6 inhibitors may provide COVID-19 benefit after all
    LONDON – The U.K. is to make treatment with interleukin-6 (IL-6) inhibitors standard of care for critically ill COVID-19 patients after a randomized trial found the arthritis drugs significantly improve survival. Read This article
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.